Jackson Financial Falls After Short-Seller Report Targets Brooke Re Structure

Jackson Financial Inc. (JXN) is down 7.4% today. Here is some analysis on what might have caused this price movement.

Analysis: The sharp move appears tied mainly to a newly published short thesis that challenged Jackson’s accounting treatment and capital presentation around its captive reinsurer, Brooke Re. That critique seems to have unsettled investors despite the company’s recently reported strong operating results, suggesting the selloff was driven more by balance-sheet concern than by core sales or earnings momentum.

Details:

A short report circulated on September 17 focused on Brooke Re and argued that a large receivable tied to hedge losses raises questions about the strength of statutory capital at Jackson National Life.

Jackson’s filings show Brooke Re is a Michigan captive reinsurer formed to take on certain variable annuity guarantee risks, making it a meaningful part of the company’s capital and risk-management framework.

The company’s most recent quarterly release had shown record second-quarter 2026 results, including higher annuity sales and strong profitability, so today’s decline does not appear to stem from a weak earnings update.

This could also be because investors reacted quickly to the complexity of the reinsurance structure itself, which can amplify downside moves when a short thesis highlights accounting or reserve-related risk.

Sources:

SEC, Jackson Financial Investor Relations, Investing.com

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$JXN Insider Trading Activity

$JXN insiders have traded $JXN stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $JXN stock by insiders over the last 6 months:

CARRIE CHELKO (EVP and General Counsel) sold 7,500 shares for an estimated $1,006,800
CHRISTOPHER RAUB (EVP JFI; CEO PPM America) sold 5,000 shares for an estimated $653,450

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$JXN Hedge Fund Activity

We have seen 231 institutional investors add shares of $JXN stock to their portfolio, and 290 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 1,018,101 shares (+inf%) to their portfolio in Q2 2026, for an estimated $104,243,361
BALYASNY ASSET MANAGEMENT L.P. added 356,955 shares (+233.7%) to their portfolio in Q2 2026, for an estimated $36,548,622
JPMORGAN CHASE & CO added 344,506 shares (+inf%) to their portfolio in Q2 2026, for an estimated $35,273,969
CITADEL ADVISORS LLC removed 333,211 shares (-91.1%) from their portfolio in Q1 2026, for an estimated $35,227,066
SCHRODER INVESTMENT MANAGEMENT GROUP removed 286,867 shares (-99.2%) from their portfolio in Q2 2026, for an estimated $29,372,312
HSBC HOLDINGS PLC added 263,838 shares (+17.8%) to their portfolio in Q2 2026, for an estimated $27,014,372
BANK OF NEW YORK MELLON CORP removed 260,014 shares (-28.5%) from their portfolio in Q2 2026, for an estimated $26,622,833

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$JXN Price Targets

Multiple analysts have issued price targets for $JXN recently. We have seen 2 analysts offer price targets for $JXN in the last 6 months, with a median target of $132.0.

Here are some recent targets:

Alex Scott from Barclays set a target price of $139.0 on 07/07/2026
Ryan Krueger from Keefe, Bruyette & Woods set a target price of $125.0 on 05/13/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.